Severity of illness (Therapeutic Index Severity Score, and direct clinical costs (labour costs, diagnostic costs, drugs, disposables, etc.) were determined for 100 consecutive patients admitted to Royal Newcastle Hospital Intensive Care Unit over six weeks. Outcome was assessed using mortality, quality of life, functional status, productivity and mental status one month after separation from the Unit. The mean total admission cost was $1,357 (Class 4 mean = $3,706) but for over 70% of patients costs were less than $1,000. The main component of cost was labour (about 60% for all classes). TISS proved a strong predictor (P<0.001) of total admission costs. Survival to one month was 89% and optimal association between cost and survival was found with those with low costs more likely to survive (P<O. 001). On the other hand, no association was found between total admission cost and resulting quality of life. However, there was an association between pre-admission and follow-up quality of life (P<0.0005).
based cost analysis research has been undertaken to date. With this background we designed this study to research the direct costs of intensive care in Australia and to define the relationship between direct cost, severity of illness and outcome. Costs identified and analysed in the study reflected the costs which vary at the bedside rather than in the accounting office. This approach would enable a detailed disclosure (which other investigations have failed to provide) of the way in which ICU costs vary as the level of severity of illness changes. The assessment of outcome would include patients' quality of life and survival, both of which had also remained unmeasured by other researchers.
METHODS
From May 10, 1983 , a prospective analysis of severity of illness, clinical course, in terms of cost, and outcome was undertaken on 100 consecutive patients admitted to the Royal Newcastle Hospital (RNH) ICV for more than eight hours. The study was approved by the Ethics Committee of RNH and satisfied the criteria of the National Health and Medical Research Council on Human Experimentation. Consent was obtained from all patients and/or their next-of-kin prior to their inclusion in the study. Inpatient data collection took place on a 24-hour basis for each day of the subject's admission. Follow-up of patients in the community took place one month after discharge from ICV.
Assessment of clinical costs
The following direct clinical costs were quantified: (1) nurses' time, (2) salaried medical staff time, (3) consultant medical staff time, (4) diagnostic tests, (5) disposables, (6) drugs, (7) intravenous fluids, (8) physiotherapy, (9) oxygen and (10) light and power.
Labour costs
Labour costs were calculated for each subject on the time spent with each subject by various categories of health professionals (medical staff, nurses and physiotherapists) using 1983 N.S.W. Public Hospital Award wages. 'Addon' costs (penalty rates, workers' compensation insurance, etc.) were included in all labour costs.
Diagnostic tests
To attempt to estimate the cost of all diagnostic tests performed in the intensive care unit was beyond the scope of this study. Therefore, these costs were calculated using the Medical Benefits Schedule Book (1983). The schedule fee for each item was calculated at the 'Specialist' rate for all tests and procedures.
Disposable costs
The term 'disposable' was defined as any item of medical equipment used for the patient's care in a procedure or other intervention which was used once and discarded. Such items included syringes, needles, catheters, tubing, combines, bandages. intravenous giving sets, etc. All such disposables used were determined for each subject throughout their admission, hospital purchase cost determined for each item and total disposable cost calculated.
Drugs cost
A record of each dose of all drugs administered to each subject during their admission was kept. Each drug cost was determined on the contract price paid by the hospital and a total drug cost determined for each patient. No hospital labour component was included.
Intravenous therapy costs
All fluids given intravenously to each subject during admission was recorded. Costs based on the wholesale price of fluids were used to calculate total intravenous fluid costs for each subject. Hyperalimentation fluids costs did not include a labour component for their preparation. Blood or blood products and labour costs of preparation were also excluded.
Oxygen costs
Oxygen was supplied to ICV by a reticulated 'wall' system from a central source. Oxygen cost was 27.8 cents/litre of liquid oxygen from the supplier. This resulted in a 'wall' oxygen cost of 0.324 cents/litre of gas. The hourly rate of oxygen consumption was calculated for each subject and a total oxygen cost determined.
Light and power costs
Light and power costs included only those electrical appliances (e.g. patient monitors, ventilators, blood warming machines, anglepoise lamps and overhead lights) used to provide direct patient care. The cost per hour to run each appliance was converted into a dollar value based on the cost of power from the supplier (11.6 cents/kilowatt hour).
Costs excluded from stuay
A pilot study estimated the cost of equipment acquisition and maintenance at $500,000 which was distributed among the total number of patients admitted to the unit over the period of time the equipment was in use (1970) (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) . This yielded an equipment cost per patient of $34.96. As this small and fixed cost did not vary at the bedside in response to the patient's severity of illness it was excluded from the patient study.
The indirect (overhead/institutional) costs of running the hospital were also excluded from the study. These costs included rent/building depreciation, building maintenance, utilities (light, power and water not attributable to patient use), support services (cleaning, food services, etc.) and administrative services. Although these costs may be passed on to the patients as charges they do not vary at the bedside and thus have no relationship to severity of illness and no influence on outcome. Indeed these costs exist even if a hospital bed remains empty.
Intangible costs of pain and suffering, personal and social costs, and the impact of an intensive care admission on the individual, family and community were also excluded. These costs, while adding to the completeness of any cost analysis, by their very nature are difficult to determine.
Costs per subject
A total admission cost for each subject was determined by adding all component costs described for each admission day to give an aggregate cost. An average daily admission cost for each subject was derived by dividing their total admission cost by the days of their admission. Severity of illness was also measured using the Therapeutic In,dex Severity Score (TISS)21,22 on admission, every day and on separation from the Unit. The daily measurement was always undertaken at 10 a.m. The 1983 version of TISS, which consisted of 76 items,23 was used. Each intervention was given a weighted score of 1 to 4. For example, an intervention such as ECG monitoring scored one point whereas controlled mechanical ventilation scored four points.
Assessment of severity of illness

Outcome
Outcome with respect to survival was determined on separation from the Unit and one month after separation.
Pre-admission Quality of Life status (QL-Index)24 was assessed retrospectively for one month prior to admission and reviewed one Anaesthesia and Intensive Care, Vol. 14, No. 4, November, 1986 month after separation. The QL-Index consisted of five items with weighted scores from 0 to 2 for each item. Scores range from 0, which indicates low qualify of life, to 10. The QL-Index contains five dimensions: activity (involvement in own occupation); activities of daily living; perception of one's own health; support of family and friends and outlook on life. The approach of Cullen et al. 21 to outcome assessment in ICU patients was also incorporated into the follow-up interview. Data were collected on each patient's condition, residential status, level of productivity, mental status and functional status. This information gave insights not gained as readily from the QL-Index.
Statistical analysis
All data collected were entered on to computer for later analysis using various BMDP statistical packages. 25 The 'non-normal' distribution of several variables necessitated the logarithmic transformation of the data for correlational analysis.
The level of statistical significance was set at P<O,OOl, using Pearson's coefficient of correlation and Pearson's Chi-square statistic. All values, where appropriate, were expressed as mean with standard deviation (SD).
RESULTS
The analysis was performed on 100 consecutive patients who were admitted to the Royal Newcastle Hospital (RNH) ICU for more than eight hours, from May 10, 1983 to June 20, 1983 . This sample of 100 patients represented 9070 to 10% of the Unit's annual number of admissions. During the study twelve persons were excluded be.cause they did not stay eight or more hours in ICU. Of those, three patients died from massive injuries after a brief admission and nine were 'wake-up' postoperative recovery patients who stayed less than three hours. The former were excluded because of the difficulty of obtaining consent and collecting data during their brief admission. The latter were excluded because they were not intensive care patients and their presence reflected an out-of -routine-hours recovery role for the unit and thus their inclusion would have biased the survey.
The age distribution of the sample did not reflect the age distribution in the general population. The ages ranged from three months to 82 years with an average of 43.7 years. Most people in the largest age category of 45-65 years had undergone elective major surgery.
The commonest (38070) primary presenting problem was trauma, which was especially evident in the younger age groups. Males made up 58% of the total sample. However, some 80% of those involved in motor vehicle accidents in the study were males. There were seven persons in the sample admitted following drug overdose, six of whom were female. Postoperative patients (36%) were the next largest group after trauma. Overall, 'surgical' patients represented 83% of the sample and the remaining 17 % consisted of subjects with 'medical' problems. The average length of stay for all subjects was 3.4 days.
Costs
The mean Total Admission Cost (T AC) for all subjects was $1357.37 (SD 2675.97). However, for 70% of subjects, TAC was less than $1000.00. The TAC varied greatly among patients and classes (Table 1 ). The mean Average Daily Cost (ADC) for all subjects was $268.18 (SD 138.87) with ADC for Class 4 subjects being 237% of Class 1 subjects (see Table 1 ).
Labour made up 54% of direct clinical costs measured for all subjects (Figure 1 ). Nursing care cost was the largest cost component being 38% of TAC ( Figure 1 Physiotherapy, other than that provided by the nursing staff, was carried out on 27% of subjects at a cost of less than $3/day. Physiotherapy represented less than 1 % of T AC, as did light and power costs.
Disposables cost constituted 9% of T AC for all subjects and varied considerably among Oxygen given to 99% of subjects averaged $1.13/ subject! day. Its delivery varied from those patients receiving 'high-flow' oxygen via face-mask to those receiving mechanical ventilation ($5/day).
Severity of illness
Twenty-four per cent of subjects were identified as critically ill (i.e. Class 4) on admission. TISS scores consistently conformed with the severity of illness of patients as judged by clinicians. In two patients, TISS points fell as severity of illness increased. In these patients, for whom further therapy was considered unwarranted, physical condition deteriorated as the level of medical intervention decreased. The average daily TISS points for all subjects was 15.6 points with considerable variation among patients within and between Classes 1 to 4 ( Table 2 ). The 71 % of subjects who scored 75 points or less for their admission were below the mean of 88 points and above the median for total TISS of 51 points. The Class 4 subjects substantially inflated the mean for all other subjects. The range of total TISS values within Class 4 was 45 to 910 points. Average daily TISS was a function ·of two variablestotal TISS and length of admission ( Table 2) . Some 80% of subjects had an initial TISS score of 20 points or less.
Severity of illness and cost
There was a strong relationship between total admission cost and severity of illness as measured by the total TISS points. The relationship with a correlation coefficient of 0.8894 (P<O.OOI) remained consistent throughout the full range of values for both variables.
Outcome and cost
There was no age or sex difference associated with a difference in outcome. Inpatient mortality was 8% and one-month mortality 11 %. There was a strong inverse association between survival and total admission cost which showed that most survivors (74%) had a total admission cost of $1000 or less (Table 3 ). In those who died during admission or prior to follow-up, 63% had a total admission cost of $1000 or more (Table 3) .
Among survivors the QL-Index at one-month follow-up closely resembled their pre-admission QL-Index (Figure 2 ). The one patient who had a pre-admission QL-index Of 0 requires comment. This patient was unconscious one month prior to admission to the RNH ICU, made a slight recovery and then relapsed into coma resulting in his transfer to the ICU. For the remaining patients, the follow-up quality of life status indicated that they were convalescing at a similar or slightly lower score than that which was determined one month prior to admission. There was an association of statistical significance between pre-admission QL and post-admission QL-Indices (Chi 2 = 101.62, with a minimum expected value of 0.01; df = 36, P<0.OOO5). While analysis of the results of the one month follow-up interview (see Table 4 ) is limited by the lack of a preadmission comparison, the interview reflected the level of response expected at one month for convalescing intensive care patients and was compatible with the QL-Indices observed at the same time. There was no association of statistical significance found between follow-up QL-Index and TAC (Chi2 = 24.33 with a minimum expected value of 0.08; df = 18, P<O.OOI).
Pre-Admission
DISCUSSION
This study sought to address the major problems limiting the usefulness of previous studies which examined the costs and outcome of intensive care. These problems include an assessment of clinical costs rather than institutional charges; measurement not only of outcome but also quality or survival, which are more discriminative than mortality Isurvival ratios; and a determination of the relationship between clinical costs, severity of illness and outcome.
The first problem of costs was addressed by determining direct clinical costs 26 rather than indirect (institutional) costs. These include professional and non-professional labour and materials utilised (e.g. drugs, disposable items, etc.). Previous ICV cost analysis has centred mostly upon hospital charges for intensive care rather than on individual resource utilisation by patients.
However, costs which are of most interest to clinicians are those which vary in response to their clinical decisions and the severity of illness of their patients. On the other hand, though institutional costs for each patient may vary from one institution to another and also with duration of ICV stay, they remain relatively constant on a daily basis in anyone unit. Thus this study has concentrated on those costs which vary greatly for individual patients such as nursing and medical care, drugs, disposables, etc. This enabled a better understanding of clinical resource utilisation and the relationship of cost and outcome.
Anaesthesia and Inrensive Care, Vol. 14, No. 4, November, 1986 The majority of costs for ICU patients and the cost of running intensive care units lie not in the cost of buildings and equipment but in the variable resources applied to the care of the critically ill, that is, labour, drugs, etc. The total establishment costs of the RNH Unit in 1983 dollars including its major equipment purchases (i.e. ventilators, ECG monitors, etc.) was estimated at approximately 0.5 million dollars, but recurrent costs exceed this figure many times annually.
There were two high-cost subjects in the sample who generated costs of $17,603.55 and $18,136.40 respectively. The Unit has 15-20 such patients per year and the aggregate cost of their admissions would pay for all the equipment in the ICU twice over. Couch et al. 27 described such patients as high-costllowfrequency events and other investigators have found costs similar to those in this study. 1.3·6,28·36
Nursing care costs, by far the greatest single component of total costs, have little potential for reduction without compromising the quality of patient care. On the other hand, medical labour costs have some potential for reduction. Although consultant medical care costs are already minimal, junior medical staff costs in Australia represent a large cost component with a potential for reduction. For example, overtime for registrar and resident staff is high and the cost of paying for that overtime is higher than employing additional staff. However, such a move would also affect the quality of the learning experience for medical staff in training positions.
Disposable costs varied greatly with severity of illness, increasing to over 10070 of total cost in Class 4 subjects where interventions such as mechanical ventilation, cel)tral venous lines and haemodialysis constituted high cost procedures. There is some potential for the reduction of disposables costs by: (1) the choice of the most effective disposable items which are not always the cheapest; and (2) systematically and quantitatively assessing the new items of disposable equipment, e.g. multi-lumen central venous catheters. Other component costs (e.g. intravenous fluids, oxygen, physiotherapy and light and power) contributed little to costs and there are few changes to clinical practice which would significantly reduce them.
Drug costs showed a tent old increase as a percentage of total costs from Classes 1 to 4. Many high-cost drug regimens form the cornerstone of current ICU practice and these costs cannot be reduced without changing many concepts of management of the critically ill. Diagnostic costs may also prove difficult to reduce beyond that reasonable level which results when close supervision by consultant staff over the ordering of such tests is maintained.
Patients receiving intensive care cannot be allocated to conventional diagnostic categories because they tend to be admitted to ICUs according to their severity of illness rather than their illness. Because of this, a therapeutic intervention scoring system (TISS) was developed by Cullen et al. 13 which sought to measure the level of medical intervention as a function of severity of illness. The use of a severity-of-illness index has facilitated cost analysis by classifying patients into groups according to the level of severity of their illness. TISS has been effective in overcoming the diagnostic diversity which had long impeded ICU research, not only for cost analysis but also to assess factors affecting outcome. However, it should be recognised that such a scoring system presumes the validity and appropriateness of interventions.
Thus, unqualified adoption of TISS scores to indicate severity of illness is misleading, as shown in those cases described where treatment was withdrawn. Moreover, some units limit invasive monitoring and other interventions to those which are directly indicated and of proven value, and so reduce TISS scores artificially as indicators of illness severity. The approach by Knaus et al. 37 of using independent physiological indices of severity of illness rather than those dependent on medical decisions offers a more promising approach to this problem.
The measurement of outcome in ICU patients has in the past been limited to their mortality/survival status. Many investigators have chosen to ignore the quality of life and functional state of the individual in addition to survival. [38] [39] [40] [41] [42] [43] Cullen et al., \,12.44 Jacobson et al. 45 and Le Gall et al. 46, 47 have attempted to assess prospectively the outcome for groups of ICU patients. There have been no uniform methods for outcome assessment, although the work of Cullen and co-workers dominates in quality and quantity ICU outcome research.
In the present study quality of life was measured by the QL-lndex, which was developed by Spitzer et al. 24 primarily for use with cancer patients. However, in the present study, it has proved suitable to assess outcome of ICU patients. The QL-lndex was easily administered and has proved to be a valid and reliable tool for outcome assessment. Followup QL-lndex in this study revealed that most of those with good health prior to admission were either in the same condition at one month follow-up or convalescing at a slightly lower score. Many subjects substantially improved their condition following lCU discharge and were mentally alert and self-sufficient in the activities of daily living. These findings refute the commonly held view that most lCU patients have very poor outcome.
The relationship between cost and outcome is complex. While the present study showed no evidence to suggest any association between cost and subsequent quality of life of survivors, there was a strong association between total admission costs and survival. That is, the relationship between 'high risk/high cost' patients and mortality described by others 1 ,4,12 was confirmed. On the other hand, if these patients survived, their outcome with respect to quality of life was not determined by their severity of current illness or admission costs but by their pre-admission health and quality-oflife status. Therefore, although one can postulate fairly accurately what will be the outcome in a certain number of patients with a certain condition, one cannot do so accurately on admission for any single patient with the condition. 9 One cannot deny intensive care to any individual solely on the basis of cost.
Costs might be contained by subjecting new and often expensive diagnostic and therapeutic technologies to rigorous analyses to determine their advantages and define their role before their widespread adoption into management protocols.
